IP Library Granted Patent US 11,273,443
Granted Patent B2
US 11,273,443 · App. 17/070,562 · Granted Mar 15, 2022

Devices and methods for molecular diagnostic testing

Inventors: Boris Andreyev (Foster City, CA); Keith E. Moravick (Mountain View, CA); Brian Ciopyk (Santa Clara, CA); Victor Briones (Gilroy, CA); Gregory Loney (Los Altos, CA); Adam De La Zerda (Los Altos, CA); Jesus Ching (Saratoga, CA); Steven Chu (Menlo Park, CA); David Swenson (Santa Clara, CA); Helen Huang (San Pablo, CA); Colin Kelly (Brooklyn, NY)
Assignee: Visby Medical, Inc.
B01L3/502715B01L3/5029B01L7/52B01L7/525B01L3/5027B01L3/527B01L2200/025B01L2200/028B01L2200/0647B01L2200/0684B01L2200/0689B01L2200/10B01L2300/0627B01L2300/0654B01L2300/0672B01L2300/0681B01L2300/0867B01L2300/0883B01L2300/18B01L2300/1822B01L2300/1844B01L2400/0457B01L2400/0478B01L2400/0487B01L2400/0605B01L2400/0611B01L2400/0644
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,273,443
App. No.
17/070,562
Granted
Mar 15, 2022
Kind
B2
Abstract

A hand-held molecular diagnostic test device includes a housing, an amplification (or PCR) module, and a detection module. The amplification module is configured to receive an input sample, and defines a reaction volume. The amplification module includes a heater such that the amplification module can perform a polymerase chain reaction (PCR) on the input sample. The detection module is configured to receive an output from the amplification module and a reagent formulated to produce a signal that indicates a presence of a target amplicon within the input sample. The amplification module and the detection module are integrated within the housing.

Claims (52)

1. A method of detecting a target nucleic acid using a molecular diagnostic test device, wherein the molecular diagnostic test device performs process steps comprising:

conveying a solution comprising a target nucleic acid from a sample input module to an amplification module;

amplifying by polymerase chain reaction the target nucleic acid to produce a target amplicon in the solution;

conveying the solution to a detection module; and

detecting the target amplicon in the solution,

wherein:

the sample input module, the amplification module, and the detection module are integrated within a housing;

the molecular diagnostic test device does not use any external instrument to perform the amplifying and detecting steps; and

the method has a sensitivity of at least about 93 percent and a specificity of at least about 95 percent for the detection of the target nucleic acid; and

wherein the molecular diagnostic test device is discarded after a single use.

2. The method of claim 1 , wherein the housing has an overall size of less than 260 cubic centimeters.

3. The method of claim 1 , wherein the solution comprises biological cells or viral particles.

4. The method of claim 3 , wherein the method comprises conveying the solution from the sample input module to a sample preparation module, lysing the biological cells or viral particles in the solution to release the target nucleic acid, and conveying the solution comprising the target nucleic acid from the sample input module to the amplification module.

5. The method of claim 1 , wherein the molecular diagnostic test device detects the target amplicon in less than about 25 minutes after the solution is conveyed into the amplification module.

6. The method of claim 1 , wherein the amplification module comprises a serpentine flow channel.

7. The method of claim 6 , wherein the molecular diagnostic test device comprises a heater coupled to the serpentine flow channel.

8. The method of claim 1 , wherein the detection module comprises a first detection surface including a first capture probe associated with the target amplicon; and a second detection surface includes a second capture probe associated with a control amplicon.

9. The method of claim 8 , wherein the control amplicon is generated by the amplifying step from a control nucleic acid.

10. The method of claim 9 , wherein the molecular diagnostic test device comprises the control nucleic acid.

11. A method for nucleic acid testing for detecting a target nucleic acid, comprising:

providing at a decentralized location a molecular diagnostic test device comprising a flow path adapted to receive a biological sample from an input module, the molecular diagnostic test device being a stand-alone molecular diagnostic test device;

applying to the input module an input biological sample comprising a polynucleotide comprising the target nucleic acid;

actuating the input module using a sample actuator or button to cause the stand-alone molecular diagnostic test device to perform process steps comprising:

conveying the biological sample into the flow path;

amplifying, by polymerase chain reaction, within the flow path, a target amplicon from the target nucleic acid; and

detecting within the same flow path, the target amplicon,

wherein the amplifying step and the detecting step are performed within the same flow path contained within a housing, and

wherein the stand-alone molecular diagnostic test device does not use any external instrument to perform the amplifying and the detecting steps; and

disposing of the stand-alone molecular diagnostic test device after a single use,

wherein the method has a sensitivity of at least about 93 percent and a specificity of at least about 95 percent for the detection of the target nucleic acid.

12. The method of claim 11 , wherein the molecular diagnostic test device is a handheld molecular diagnostic test device.

13. The method of claim 11 , wherein the housing has an overall size of less than about 260 cubic centimeters.

14. The method of claim 11 , further comprising, after the applying step, lysing the input biological sample within the flow path.

15. The method of claim 11 , wherein the detecting step is performed in a time of less than about 25 minutes from the applying step.

16. The method of claim 11 , wherein the flow path forms a continuous reaction volume.

17. The method of claim 11 , wherein the molecular diagnostic test device comprises a positive control stored in liquid form or as a lyophilized bead.

18. The method of claim 11 , wherein the molecular diagnostic test device comprises an amplification module for performing the amplifying step and a detection module for performing the detection step.

19. The method of claim 18 , wherein the amplification module and the detection module are each integrated within the housing of the molecular diagnostic test device.

20. The method of claim 11 , wherein the flow path crosses one or more heaters at multiple different points within the molecular diagnostic test device.

21. The method of claim 18 , wherein the flow path comprises a serpentine flow channel within the amplification module.

22. The method of claim 21 , wherein the molecular diagnostic test device comprises a heater coupled to the serpentine flow channel.

23. The method of claim 11 , wherein the amplifying step comprises amplifying by polymerase chain reaction (PCR).

24. The method of claim 18 , wherein the detection module comprises a first detection surface including a first capture probe associated with the target amplicon; and a second detection surface includes a second capture probe associated with a control amplicon.

25. The method of claim 24 , wherein the molecular diagnostic test device comprises a control nucleic acid.

26. A method of detecting a target nucleic acid using a molecular diagnostic test device, wherein the molecular diagnostic test device performs, at most one time before the molecular diagnostic test device is discarded, process steps comprising:

conveying a solution comprising a target nucleic acid from a sample input module to an amplification module;

amplifying by polymerase chain reaction the target nucleic acid to produce a target amplicon in the solution;

conveying the solution to a detection module; and

detecting the target amplicon in the solution, wherein

the sample input module, the amplification module, and the detection module are integrated within a housing,

the molecular diagnostic test device does not use any external instrument to perform the amplifying and the detecting steps,

the method has a sensitivity of at least about 93 percent and a specificity of at least about 95 percent for the detection of the target nucleic acid.

Assignments (5)
SECURITY INTEREST Recorded Mar 7, 2025
From: VISBY MEDICAL, INC.
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 070442/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2020
From: CHU, STEVEN
To: CLICK DIAGNOSTICS, INC.
Reel/Frame 054055/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2020
From: MORAVICK, KEITH E.
To: CLICK DIAGNOSTICS, INC.
Reel/Frame 054055/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2020
From: ANDREYEV, BORIS; CIOPYK, BRIAN; BRIONES, VICTOR; LONEY, GREGORY; DE LA ZERDA, ADAM; CHING, JESUS; KELLY, COLIN; SWENSON, DAVID; HUANG, HELEN
To: CLICK DIAGNOSTICS, INC.
Reel/Frame 054084/0239 →
CHANGE OF NAME Recorded Oct 14, 2020
From: CLICK DIAGNOSTICS, INC.
To: VISBY MEDICAL, INC.
Reel/Frame 054084/0263 →
Continuity (7)
Continuation 15999820 · Aug 23, 2018
Continuation 15474083 · Mar 30, 2017
Division 14984573 · Dec 30, 2015
Provisional Application 62213291 · Sep 2, 2015
Provisional Application 62098769 · Dec 31, 2014
Related Publication 20210039097A1 · Feb 11, 2021
Related Publication 20210354132A9 · Nov 18, 2021
Cited By (4)
US 1,064,314 US 1,076,140 US 1,123,184 US 12,239,993